Gout flares are commonly treated with colchicine, which can provoke GI side effects, particularly diarrhea. The Acute Gout Flare Receiving Colchicine Evaluation (AGREE) trial investigated the efficacy ...

For this study, investigators initially screened 813 patients, each with a known history of gout. Of this group, 575 met the inclusion criteria that included age ≥ 18 years, a confirmed diagnosis of ...

The anti-inflammatory agent colchicine, started within 24 hours of acute ischemic stroke or a transient ischemic attack (TIA), was not associated with a reduction in subsequent strokes or other ...

EKSTROM trial results demonstrate low-dose colchicine, 0.5 mg significantly reduced total plaque volume in stable coronary artery disease compared to placebo at one year PARSIPPANY, N.J., March 31, ...

IN a previous report 1 I described my experience with colchicine in 2 patients with sarcoid arthritis. In the first, each of four acute bouts of joint inflammation was abruptly terminated in less than ...

Both ABP-671 and ABP-745 have the potential to give gout patients more effective and safer alternatives to existing gout therapies.

Please provide your email address to receive an email when new articles are posted on . In patients with chronic coronary disease, adding low-dose colchicine to optimal medical therapy reduced risk ...

ORLANDO, Fla. — Late-breaking data from the COPPS-POAF trial demonstrate that colchicine was safe and effective in reducing postoperative atrial fibrillation. According to Massimo Imazio, MD, the drug ...

PHILADELPHIA, PA—Colchicine, given orally prior to PCI in an all-comers population, does not reduce procedure-related myocardial injury, but does appear to attenuate the inflammatory response, results ...

Background A 56-year-old white woman was referred to our institution with a 16-month history of severe, gouty, recurrent, acute polyarthritis involving the finger joints. She also had numerous small ...

Low-dose colchicine appeared to be as effective as a more conventional dose in treating acute gout flares, but produced far fewer side effects in randomized, double blind, placebo-controlled trial in ...